Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

TLR2 and autism spectrum disorder are reported together in 2 articles.

Gene

TLR2

HGNC
HGNC:11848
78articles
78mentions
9variants with confirmed gene link
Most co-reported phenotypes (articles)
Reported variants (articles · ClinVar status)
HPO
HP:0000729
881articles
881mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

2 records shown · first 60
TypeEntitySource evidenceConfidenceExtractor
geneTLR2“We investigated the effect of resveratrol treatment on TLR2, TLR3, TLR4, NF-κB, and inducible nitric oxide synthase (iNOS or NOS2) levels in CD4 spleen cells.”0.98hgnc_dict_v1
phenotypeautism spectrum disorder“Autism is a neurodevelopmental disorder characterized by deficits in qualitative impairments in communication, repetitive and social interaction, restricted, and stereotyped patterns of behavior.”0.93phenotype_alias_lexicon_v2
geneTLR4“Here, we explored whether resveratrol treatment decreases neuroimmune dysregulation mediated through toll-like receptor (TLR4) and nuclear factor-κB (NF-κB) signaling pathway in BTBR mice.”0.98hgnc_dict_v1
geneTLR3“We investigated the effect of resveratrol treatment on TLR2, TLR3, TLR4, NF-κB, and inducible nitric oxide synthase (iNOS or NOS2) levels in CD4 spleen cells.”0.98hgnc_dict_v1

Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T+ Itpr3tf/J mice.

PMID 28668513 | DOI 10.1016/j.pnpbp.2017.06.034 · Progress in neuro-psychopharmacology & biological psychiatry · 2017 · 6 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneTLR2“Treatment of BTBR mice with SCH increased the percentage of splenic CD14+TLR2+ cells, CD14+TLR3+ cells, CD14+TLR4+ cells, and decreased the percentage of CD14+IL-27+ cells, as compared to the untreated BTBR mice.”0.98hgnc_dict_v1
phenotypeautism spectrum disorder“Autism is a predominant neurodevelopmental disorder characterized by impaired communication, social deficits, and repetitive behaviors.”0.93phenotype_alias_lexicon_v2
geneCD14“Treatment of BTBR mice with SCH increased the percentage of splenic CD14+TLR2+ cells, CD14+TLR3+ cells, CD14+TLR4+ cells, and decreased the percentage of CD14+IL-27+ cells, as compared to the untreated BTBR mice.”0.98hgnc_dict_v1
geneTLR3“Treatment of BTBR mice with SCH increased the percentage of splenic CD14+TLR2+ cells, CD14+TLR3+ cells, CD14+TLR4+ cells, and decreased the percentage of CD14+IL-27+ cells, as compared to the untreated BTBR mice.”0.98hgnc_dict_v1